Max

Max

Max

Market Access

Market Access

X-factor

X-factor

Your reps are waiting for answers. One phone number. Information in 90 seconds. Back in the field.

Your reps are waiting for answers. One phone number. Information in 90 seconds. Back in the field.

Your reps are waiting for answers. One phone number. Information in 90 seconds. Back in the field.

The status quo is broken.

The status quo is broken.

The status quo is broken.

A field rep needs coverage information. They email the market access shared inbox. The question arrives without the payer, account, plan, or patient-support context needed to answer it.

A field rep needs coverage information. They email the market access shared inbox. The question arrives without the payer, account, plan, or patient-support context needed to answer it.

Two or three days later, someone replies with clarifying questions. The thread turns into back-and-forth before the real answer can be delivered. By then, the moment is gone — and the same questions are still getting asked across the field.

Two or three days later, someone replies with clarifying questions. The thread turns into back-and-forth before the real answer can be delivered. By then, the moment is gone — and the same questions are still getting asked across the field.

Question → Missing Context → Clarifying Thread → Late Answer

Question → Missing Context → Clarifying Thread → Late Answer

Both leaders gain clarity.

Both leaders gain clarity.

Both leaders gain clarity.

For the Sales Leader

Market access information is nuanced. When a rep has to ask a clarifying question, it can go to the wrong person, sit in the wrong queue, or lose the context needed to answer it well.

Max pulls context directly from company documents, so reps don’t have to guess which detail matters. It answers when it can, and when it can’t, it works like a switchboard — routing the question to the right person with the right context already attached.

Better context. Better routing. Faster field confidence.

For the Market Access Leader

Your team should be focused on PBM strategy, utilization management improvements, and account execution — not repeatedly translating the same field questions into usable context.

Max scales your knowledge across the field, logs every question, and reveals where coverage, account structure, or patient-support confusion is slowing execution. FTE capacity can shift from inbox triage to forward-deployed reimbursement support.

Your experts stay strategic. Max handles the repeatable work.

For the Sales Leader

Market access is nuanced. Max uses company documents to answer with context, and when a question needs a person, it routes it like a switchboard — already packaged with the details the team needs.

Better context. Better routing. Faster field confidence.

Commercial execution breaks when the field works in fragments.

Commercial execution breaks when the field works in fragments.

Commercial execution breaks when the field works in fragments.

Join, or Die snake illustration showing fragmented commercial field teams

Max connects field sales, reimbursement, patient support, and account teams so questions move with context — not through inbox archaeology.

Max connects field sales, reimbursement, patient support, and account teams so questions move with context — not through inbox archaeology.

Request beta access

Request beta access

Request beta access

Max is in private beta. If you’ve been invited to evaluate the workflow, or if you want to request access for your team, email SCRIPTYAK and we’ll follow up directly.

Max is in private beta. If you’ve been invited to evaluate the workflow, or if you want to request access for your team, email SCRIPTYAK and we’ll follow up directly.

Invite-only beta

Invite-only beta

Max is currently available by invitation for select commercial and market access teams. Email us to request access and include your company, drug or therapeutic area, launch stage, and the best way to reach you.

Max is currently available by invitation for select commercial and market access teams. Email us to request access and include your company, drug or therapeutic area, launch stage, and the best way to reach you.

Please avoid sending confidential patient information through email. Enterprise use of Max is governed separately by written agreements, as applicable.

Please avoid sending confidential patient information through email. Enterprise use of Max is governed separately by written agreements, as applicable.

SCRIPTYAK, Inc.

SCRIPTYAK, Inc.

© 2026 SCRIPTYAK, Inc. All rights reserved.

© 2026 SCRIPTYAK, Inc. All rights reserved.

SCRIPTYAK is a registered trademark of SCRIPTYAK, Inc.

SCRIPTYAK is a registered trademark of SCRIPTYAK, Inc.